Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
475,746
-
Share change
-
-20,472
-
Total reported value
-
$2,582,000
-
Price per share
-
$5.42
-
Number of holders
-
14
-
Value change
-
-$55,242
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q1 2018
As of 31 Mar 2018,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
475,746 shares.
The largest 10 holders included
Ibex Investors LLC, BANK HAPOALIM BM, Vantage Investment Advisors, LLC, HighTower Advisors, LLC, Psagot Investment House Ltd., Harel Insurance Investments & Financial Services Ltd., RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, DAFNA Capital Management LLC, and LADENBURG THALMANN FINANCIAL SERVICES INC..
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.